United Therapeutics CEO Rothblatt Reports $5.7 Million Share Sale
United Therapeutics Chairperson and CEO Martine A. Rothblatt reported selling $5.7 million in common shares.
United Therapeutics Chairperson and CEO Martine A. Rothblatt reported selling $5.7 million in common shares.